11 results
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Dyspnea - Considerations ... Lymphangitic spread to lung ... pericardial effusion - Lung ... NEJMcps1414168 #dyspnea ... #algorithm #differential
POCUS Lung Algorithm for the Use of Ultrasound in the Evaluation of Dyspnea 

#Diagnosis #Management #CriticalCare
POCUS Lung Algorithm ... for the Use of Ultrasound ... Evaluation of Dyspnea ... #Algorithm #Ddxof ... #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... with lung-rockets ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #Ultrasound
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... with lung-rockets ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #Ultrasound
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
known or suspected malignant ... goals of assessing lung ... and relief of dyspnea ... the patient’s dyspnea ... Effusions #MPE #Algorithm
Causes of Interstitial Lung Disease - Differential Diagnosis Algorithm
Idiopathic Interstitial Pneumonia
 • (UIP) Usual Interstitial Pneumonia
of Interstitial Lung ... Differential Diagnosis Algorithm ... slowly progressive dyspnea ... Atypical” Pneumonia Malignancy ... Differential #Diagnosis #Algorithm
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
septations in Malignant ... Effusion (MPE) - Lung ... prospective e/o dyspnea ... Effusion #MPE #Lung ... POCUS #clinical #ultrasound
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
infections Lungs ... to NTM: Chronic lung ... of right middle lobe ... Hematologic malignancy ... Weakness, • Dyspnea
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... Progression: • Upper lobe ... lung involvement ... hemoptysis • Dyspnea ... tracheobronchial stenosis, malignancy
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... Progression: • Upper lobe ... lung involvement ... hemoptysis • Dyspnea ... tracheobronchial stenosis, malignancy